Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 27,645 $ 85,451
Marketable securities, current 63,361 39,633
Prepaid expenses 3,347 2,318
Grants revenue receivable 5,900 7,100
Accounts receivable, related party 3,167 408
In-process research and development - held for sale 4,500 4,500
Other current assets 160 489
Total current assets 108,080 139,899
Marketable securities, non-current 0 1,510
Operating lease right-of-use assets, non-current 9,266 9,959
Property and equipment, net 20,224 18,158
Other assets 4,840 4,676
Total assets 142,410 174,202
Current liabilities:    
Accounts payable 1,660 1,465
Accrued liabilities 14,129 14,544
Deferred revenue, current 13,284 8,511
Deferred revenue, current, related party 5,218 8,780
Other current liabilities, related party 5,325 0
Other current liabilities 1,785 2,501
Total current liabilities 41,401 35,801
Deferred revenue, long-term 9,728 18,944
Deferred revenue, long-term, related party 1,849 441
Long-term debt, net 14,721 2,940
Operating lease liabilities, non-current 10,771 11,682
Other liabilities, related party 6,654 0
Other liabilities 1,427 1,366
Total liabilities 86,551 71,174
Commitments and contingencies (Note 10) 0 0
Stockholders’ equity    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at June 30, 2020 and December 31, 2019; issued and outstanding: 250 shares at June 30, 2020 and December 31, 2019 0 0
Common stock, $0.001 par value: Authorized: 150,000,000 shares at June 30, 2020 and December 31, 2019; issued and outstanding: 45,778,876 shares at June 30, 2020 and 45,589,157 shares at December 31, 2019 46 46
Additional paid-in capital 273,012 267,089
Accumulated other comprehensive income 172 18
Accumulated deficit (217,371) (164,125)
Total stockholders’ equity 55,859 103,028
Total liabilities and stockholders’ equity $ 142,410 $ 174,202